Track topics on Twitter Track topics that are important to you
DAMASCAS, MD., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Syndication Inc., (SYNJ.PK), reports that on August 4th, 2015, the CEO asked the board for a vote approving a 2nd marketing and network distribution agreement for its "ARHCER" trading software and Day TradeXchange trade room membership subscription sales. The company notes that the proposed partner is an internationally known full service and day trading broker dealer with more than 35 thousand currently active trading brokerage accounts. The Company noted that ARCHER is quickly being recognized as one of the most advanced forecasting trade indicators available to non-institutional day traders today. Investors interested in the stock of the Company should not overlook the potential impact of ARCHER's ability to use an effortless and seemliness "point and click" delivery and distribution system to generate sales. The indicator is software that requires no production facility, no shipping or handling, and is accessible by simply clicking the icon on the trading platform currently being used by the day trader. Billing is automatic and can be handled as an add-on feature through the normal monthly billing cycle of the broker dealer or trading platform being used by the trader.
On other events the Company's first phase of its sales program was launched at 5:00 PM EST yesterday August 10th, 2015. The company targeted a small and specific demographic market designed to test the marketing and software implantation systems to access its functionality and efficiency before initiating scheduled increases in marketing volume.
On a closing note, the Company stated that it currently has absolutely no intention or plans to reverse split its stock at any time in the near future and that related concerns are unfounded. Sighting that the last capital reverse as outlined in the 1st Quarter Financial Statement, was a condition of the ARCHER acquisition and the material transfer of ownership to two new principles of our Day TradeXchange subsidiary.
"FREE LIVE TRADING ROOM VISITORS PASS"
DTX invites traders of all experience and those simply curious about day trading to watch and listen to our professional traders make live trade calls in the DTX trading room. To schedule a FREE LIVE TRADING ROOM VISITORS PASS simply go to www.daytradexchange.com and enter your e-mail address and a trading coordinator will contact you with arrangements, (no credit card required). Login to DTX's live trading room from your computer and witness professional traders call trades in crude oil (CL), natural gas (NG), Russell 2000 (TF), Euro Currency (6E), S &P 500 (ES) and other futures markets. The trading room is open to members 24/7 but, only hosted by professional traders Monday - Friday 8:30 to 11:30 AM EST. Day traders hold no open positions overnight and depending on market conditions, trades can happen relatively quick. With holding times of less than 5 minutes the trading room can provide many opportunities to profit. Witness firsthand how the ARCHER trading indicator provides our members with the trading edge they need to become profitable day traders.
Subscriptions are temporarily available at a promotional discount rate of $197 per month to mark the opening of the DTX trading room. Contact the Company to register for your FREE LIVE TRADING ROOM VISITORS PASS. Additional information on quarterly, semi-annual and annual trading room subscription packages as well as the ARCHER Software lease program is available by calling DTX at 888-422-5515 or by going to; http://daytradexchange.com and entering your e-mail address. Active traders are welcome to call and take advantage of our FREE 3 DAY live trading room trial.
Day TradeXchange, where day traders trade…….
Archer in the News
Follow DTX on:
DTX YouTube, Trade of the Day: https://www.youtube.com/channel/UCy6cbOBL89UpZEC5tKlyeBg
STOCK RADIO; LIVE Interview with Syndication CEO, Brian Sorrentino; http://thestockradio.com/otcpink-synj-syndication-inc-ceo-brian-sorrentino-2013.html
Written Correspondence; PO Box 503, Damascus, MD 20872
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in in pervasive markets.
CONTACT: John Ford Director of Sales 1-888-422-5515 email@example.comNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...